Difficulty: Medium
Average Score: 83%
Practice
A 36 year old woman presented with weakness, lassitude and feeling easily tired. Her bone marrow aspirate showed 15% myeloblasts and reduced erythropoiesis. The most likely cause is
Correct answer
A
Rationale
In this case, the correct answer is A) Acute myeloid leukaemia (AML). AML is a type of cancer that starts in the bone marrow and quickly moves into the blood. The symptoms described in the question, such as weakness, lassitude, fatigue, and the presence of myeloblasts in the bone marrow aspirate, are indicative of AML. The reduced erythropoiesis seen in the bone marrow aspirate also points towards AML as it affects the production of all types of blood cells including red blood cells.
Now let's look at why the other options are incorrect:
B) Acute lymphoid leukaemia (ALL) primarily affects lymphoid cells, not myeloid cells. The symptoms and bone marrow findings described in the question are more indicative of a myeloid disorder.
C) Myelofibrosis is characterized by the replacement of bone marrow tissue with fibrous scar tissue, leading to anemia, fatigue, and an enlarged spleen. It typically presents differently than the symptoms described in the question.
D) Myelodysplastic syndrome (MDS) is a group of disorders where the bone marrow does not produce enough healthy blood cells. While MDS can present with similar symptoms, the presence of myeloblasts in the bone marrow aspirate is more indicative of AML.
Educationally, understanding the differentiation between hematological disorders is crucial for accurate diagnosis and management. Knowing the clinical presentation, diagnostic findings, and underlying pathophysiology of conditions like AML, ALL, myelofibrosis, and MDS is vital for healthcare professionals involved in the care of patients with hematological issues. This knowledge helps in providing appropriate and timely interventions to improve patient outcomes.
Now let's look at why the other options are incorrect:
B) Acute lymphoid leukaemia (ALL) primarily affects lymphoid cells, not myeloid cells. The symptoms and bone marrow findings described in the question are more indicative of a myeloid disorder.
C) Myelofibrosis is characterized by the replacement of bone marrow tissue with fibrous scar tissue, leading to anemia, fatigue, and an enlarged spleen. It typically presents differently than the symptoms described in the question.
D) Myelodysplastic syndrome (MDS) is a group of disorders where the bone marrow does not produce enough healthy blood cells. While MDS can present with similar symptoms, the presence of myeloblasts in the bone marrow aspirate is more indicative of AML.
Educationally, understanding the differentiation between hematological disorders is crucial for accurate diagnosis and management. Knowing the clinical presentation, diagnostic findings, and underlying pathophysiology of conditions like AML, ALL, myelofibrosis, and MDS is vital for healthcare professionals involved in the care of patients with hematological issues. This knowledge helps in providing appropriate and timely interventions to improve patient outcomes.